MASIMO CORP Action · US5747951003 · MASI · 578074 (XNAS) États-Unis · Healthcare — cotations et cours en temps réel, données d'entreprise, dividendes, fondamentaux et analyse de portefeuille IA sur MoneyPeak

Aperçu

Analyse alimentée par l’IA

Analyse fondamentale

Découvrez ce que disent vraiment les chiffres — avant le marché

Analyser maintenant

Sentiment des actualités

Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?

Analyser maintenant

Acheter / Conserver / Vendre

Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.

Analyser maintenant

Évaluation des risques

Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.

Analyser maintenant

Juste valeur

Cette action est-elle bon marché, correctement valorisée ou surévaluée ?

Analyser maintenant

Dernières analyses d’IA sur MASIMO CORP

Résumé de la Note des Analystes

Achat

Achat fort

Achat

Conserver

Vente

Vente forte

Pas de cours

Notation du Risque ESG

B Bon

Flottant et Liquidité des Actions

Flottant Libre 84,60 %

Actions en Flottant 44,31 M

Actions en Circulation 52,37 M

Fonds investis

Les fonds suivants ont investi dans MASIMO CORP :

Fonds AltShares Trust - AltShares Merger Arbitrage ETF	Vol. en millions 184,17	Part (%) 2,81 %
Fonds ETF Managers Trust - ETFMG Prime 2x Daily Junior Silver Miners ETF	Vol. en millions 9,03	Part (%) 1,03 %
Fonds iShares US Medical Devices UCITS ETF USD (Acc)	Vol. en millions 441,04	Part (%) 0,79 %
Fonds JPMorgan U.S. Minimum Volatility ETF	Vol. en millions 90,90	Part (%) 0,47 %
Fonds John Hancock Multifactor Health Care ETF	Vol. en millions 200,42	Part (%) 0,41 %

Profil de l'entreprise pour MASIMO CORP Action

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.